Compounds > lutetium
Page last updated: 2024-08-22

lutetium and Carcinoma, Anaplastic

lutetium has been researched along with Carcinoma, Anaplastic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
de Feijter, JM; Seijkens, TTP; van Golen, LW; Vogel, W1
Ahmadzadehfar, H; Bundschuh, RA; Eppard, E; Essler, M; Gaertner, FC; Khawar, A; Kürpig, S; Meisenheimer, M; Roesch, F; Sinnes, JP1
Eriksson, SE; Nilsson, R; Ohlsson, T; Tennvall, J1
Batra, SK; Chauhan, SC; Colcher, D; Gwilt, PR; Jain, M; Li, J; Moore, ED; Wittel, UA1

Other Studies

4 other study(ies) available for lutetium and Carcinoma, Anaplastic

ArticleYear
Peritoneal Metastases From Prostate Carcinoma Treated With 177 Lu-PSMA-I&T.
    Clinical nuclear medicine, 2023, May-01, Volume: 48, Issue:5

    Topics: Aged; Carcinoma; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome

2023
Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:7

    Topics: Aged; Carcinoma; Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Neoplasm Metastasis; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiation Dosage; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Scandium

2018
Repeated radioimmunotherapy with 177Lu-DOTA-BR96 in a syngeneic rat colon carcinoma model.
    Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Blood Platelets; Body Weight; Carcinoma; Cell Line, Tumor; Colonic Neoplasms; Dose-Response Relationship, Radiation; Immunoconjugates; Leukocytes; Lutetium; Male; Radioimmunotherapy; Radioisotopes; Rats; Rats, Inbred BN

2012
Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49.
    European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:3

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Carcinoma; Female; Immunoglobulin Fragments; Lutetium; Metabolic Clearance Rate; Mice; Mice, Nude; Organ Specificity; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution

2005